Class III
Terminated
Lamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by: Unichem Laboratories LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511 India; Marketed by: Unichem Pharmaceuticals (USA), Inc ., Rochelle Park, NJ 07662; NDC 29300-113-05.
This recall has been terminated (originally issued October 5, 2016).
- Company
- Unichem Pharmaceuticals Usa Inc
- Recall Initiated
- August 19, 2016
- Posted
- October 5, 2016
- Recall Number
- D-1519-2016
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 368 bottles
- Firm Location
- Hasbrouck Heights, NJ, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.
Distribution
Nationwide
Lot / Code Info
Lot #: GLEH 16003, Exp 03/31/18
More recalls by Unichem Pharmaceuticals Usa Inc
Other recent Class III Drug recalls
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Via...
Slate Run Pharmaceuticals
· Mar 4, 2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceutica...
Unichem Pharmaceuticals Usa Inc.
· Feb 18, 2026
parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL),...
Haleon Us Holdings Llc
· Feb 4, 2026
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceutic...
Novadoz Pharmaceuticals Llc
· Feb 4, 2026
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd.,...
Cipla Usa, Inc.
· Jan 28, 2026